You are here

  • Home
  • Archive
  • Volume 75, Issue 6
  • Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

Article info

Article menu
Download PDFPDF
Viewpoint
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

Authors

  1. Correspondence to Dr Cindy Strehl, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Charitéplatz 1, Berlin 10117, Germany; cindy.strehl{at}charite.de
View Full Text

Citation

Strehl C, Bijlsma JWJ, de Wit M, et al
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
Annals of the Rheumatic Diseases 2016;75:952-957.

Publication history

  • Received November 18, 2015
  • Revised January 25, 2016
  • Accepted February 13, 2016
  • First published March 1, 2016.
Online issue publication 
October 31, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/